WHAT WE DO?
AC Nova Technologies Inc. (ATI) partners in the design, development, and research of innovative healthcare technologies and products. Our long-term objective is to identify and advance over-the-counter (OTC) medicines, medical devices, and emerging health technologies that are supported by evidence-based clinical research.
ATI conducts and supports clinical research required for regulatory approval of OTC medicines and medical devices. Our research programs are designed to meet the standards required for approval by Health Canada and the U.S. Food and Drug Administration (FDA).
ATI's strategic objective is to identify and acquire promising OTC natural medicines, medical devices, and related health technologies. Where appropriate, ATI will pursue regulatory approvals and develop pathways for distribution, licensing, or manufacturing of these products. Our clients and partners include:
- Medical practitioners
- Pharmacies
- Medical clinics
- Defense and government organizations
Through scientific research, innovation, and regulatory expertise, ATI aims to bring validated healthcare technologies to market efficiently and responsibly.
Services Clinical Research & Independent Scientific Analysis ATI conducts clinical research and provides independent scientific evaluation to support the development and regulatory approval of OTC medicines and medical technologies.
Artificial Intelligence Data Data Analysis
ATI uses artificial intelligence and advanced data analytics to evaluate and synthesize complex scientific and clinical datasets. Our AI-driven approach supports:
- Evidence evaluation
- Clinical research analysis
- Scientific data interpretation
- Strategic advisory services for product development
3D Printing for Medical Applications
ATI is developing portable 3D printing technologies for prosthetic and orthopedic applications, including devices designed to stabilize fractures and support rapid medical response in remote or field environments. These innovations aim to improve accessibility, customization, and speed of care in both clinical and emergency settings.
Laser Therapy Technologies
ATI evaluates and identifies evidence-based laser therapy technologies for the treatment of:
- Joint injuries
- Pain management
- Inflammatory conditions
- Traumatic brain injuries
Our goal for 2026-2027 is to acquire, license, or distribute clinically validated laser therapies that meet regulatory standards and demonstrate measurable patient benefits. Technologies currently under review include:
- Domer Laser Therapy (FDA approved)
- BioFlexor Laser Therapy (Health Canada approved)
